Five-Membered N‑Heterocyclic Scaffolds as Novel Amino Bioisosteres at γ‑Aminobutyric Acid (GABA) Type A Receptors and GABA Transporters

Given the heterogeneity within the γ-aminobutyric acid (GABA) receptor and transporter families, a detailed insight into the pharmacology is still relatively sparse. To enable studies of the physiological roles governed by specific receptor and transporter subtypes, a series of GABA analogues compri...

Full description

Saved in:
Bibliographic Details
Published in:Journal of medicinal chemistry Vol. 62; no. 12; pp. 5797 - 5809
Main Authors: Giraudo, Alessandro, Krall, Jacob, Bavo, Francesco, Nielsen, Birgitte, Kongstad, Kenneth T, Rolando, Barbara, De Blasio, Rossella, Gloriam, David E, Löffler, Rebekka, Thiesen, Louise, Harpsøe, Kasper, Frydenvang, Karla, Boschi, Donatella, Wellendorph, Petrine, Lolli, Marco L, Jensen, Anders A, Frølund, Bente
Format: Journal Article
Language:English
Published: United States American Chemical Society 27-06-2019
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Given the heterogeneity within the γ-aminobutyric acid (GABA) receptor and transporter families, a detailed insight into the pharmacology is still relatively sparse. To enable studies of the physiological roles governed by specific receptor and transporter subtypes, a series of GABA analogues comprising five-membered nitrogen- and sulfur-containing heterocycles as amine bioisosteres were synthesized and pharmacologically characterized at native and selected recombinant GABAA receptors and GABA transporters. The dihydrothiazole and imidazoline analogues, 5–7, displayed moderate GAT activities and GABAA receptor binding affinities in the mid-nanomolar range (K i, 90–450 nM). Moreover, they exhibited full and equipotent agonist activity compared to GABA at GABAA-αβγ receptors but somewhat lower potency as partial agonists at the GABAA-ρ1 receptor. Stereoselectivity was observed for compounds 4 and 7 for the GABAA-αβγ receptors but not the GABAA-ρ1 receptor. This study illustrates how subtle differences in these novel amino GABA bioisosteres result in diverse pharmacological profiles in terms of selectivity and efficacy.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0022-2623
1520-4804
DOI:10.1021/acs.jmedchem.9b00026